High-risk alpha-human papillomavirus types: Detection in HIV-infected children with acquired epidermodysplasia verruciformis

Journal of the American Academy of Dermatology

Volumn 68, Issue 2, 2013, Pages 343-345

  Vicente, Asunción ^a   Pau Charles, Ignasi ^a   González Enseñat, Maria Antonia ^a   Muñoz Almagro, Carmen ^a   Cañadas, Mari P ^b   Noguera Julian, Antoni ^a   Fortuny, Claudia ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b General Lab   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; GLYCOLIC ACID; IMIQUIMOD; RETINOID;

CANCER RISK; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; EPIDERMODYSPLASIA VERRUCIFORMIS; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LETTER; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; VIRUS DETECTION; VIRUS LOAD; WART VIRUS; WART VIRUS ALPHA;

EID: 84872280669     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.08.026     Document Type: Article

References (4)

1. H.D. Rogers, J.L. Macgregor, K.M. Nord, S. Tyring, P. Rady, and D.E. Engler Acquired epidermodysplasia verruciformis J Am Acad Dermatol 60 2009 315 320
2. S. Jacobelli, H. Laude, A. Carlotti, F. Rozenberg, J. Deleuze, and J.P. Morini Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy Arch Dermatol 147 2011 590 596
3. E. Huiras, V. Preda, T. Maurer, and M. Whitfeld Cutaneous manifestations of immune reconstitution inflammatory syndrome Curr Opin HIV AIDS 3 2008 453 460
4. R.H. Gormley, and C.L. Kovarik Dermatologic manifestations of HPV in HIV-infected individuals Curr HIV/AIDS Rep 6 2009 130 138